Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KREBSBIO.NSthis companyKrebs Biochemicals & Industries Limited	₹59.62	-5.06×	-0.53×	3.61×	-90.67×	-393.1%	27.5%	-50.0%	-71.4%	10.4%	-10.7%	-14.2%	-1.38×	-65.63×	-1.68×	0.09×	0.0%	4	-0.63	1	C-
ACHYUT.BOAchyut Healthcare Ltd.	₹8.09	532.32×	3.54×	17.22×	264.63×	-352.1%	16.8%	1.2%	3.3%	0.7%	0.2%	-5.6%	0.04×	-3.9×	30.1×	4.59×	0.0%	5	23.86	2	C+
ALALPA.BOAlpa Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ALPA.NSAlpa Laboratories Limited	₹56.58	6.52×	0.52×	0.92×	5.12×	43.1%	12.9%	1.1%	14.2%	8.1%	0.6%	8.7%	0.01×	-0.02×	4.64×	4.01×	0.0%	5	—	2	B-
BABALPHARMA.BOBal Pharma Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BALPHARMA.NSBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
Peer median	—	15.3×	1.17×	0.92×	7.34×	43.1%	16.8%	1.2%	3.3%	7.6%	0.6%	-4.2%	0.04×	-0.02×	4.64×	4.01×	0.0%	5	23.86	2	—